MCM
HALO icon

Manchester Capital Management’s Halozyme HALO Stock Holding History

Manchester Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-320
Closed -$14K – 931
2022
Q2 		$14K Hold
320
– – ﹤0.01% 449
2022
Q1 		$13K Sell
320
-318
-50% -$11.3K ﹤0.01% 511
2021
Q4 		$26K Hold
638
– – ﹤0.01% 453
2021
Q3 		$26K Buy
638
+583
+1,060% +$24.4K ﹤0.01% 484
2021
Q2 		$2K Buy
+55
New +$2.43K ﹤0.01% 686

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manchester Capital Management's HALO Position: Q3 2022 in Review

Manchester Capital Management sold out of Halozyme (HALO) in Q3 2022, closing a stake of 320 shares — an estimated $14K sold.

Manchester Capital Management first reported a position in HALO in Q2 2021 and held it in 5 quarters. The position peaked at $26K in Q4 2021. 357 funds tracked by Wall St. Rank hold HALO as of Q3 2022.

  • Manchester Capital Management reported no remaining Halozyme position as of Q3 2022 after selling out during the quarter.
  • Manchester Capital Management sold 320 Halozyme shares in Q3 2022, an estimated $14K.
  • Manchester Capital Management first reported a position in Halozyme in Q2 2021 and held it in 5 quarters.
  • Manchester Capital Management's Halozyme position peaked at $26K in Q4 2021.
  • 357 funds tracked by Wall St. Rank held Halozyme as of Q3 2022.

Based on Manchester Capital Management's 13F filing for Q3 2022, filed 8 Nov 2022.